Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125643601 | 12564360 | 1 | I | 20160715 | 20160718 | 20160718 | EXP | US-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00318 | SCIEGEN | 86.00 | YR | F | Y | 0.00000 | 20160717 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125643601 | 12564360 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Unknown | 20 MG DAILY | U | 205519 | 20 | MG | TABLET | ||||||
| 125643601 | 12564360 | 2 | I | Sitagliptin | SITAGLIPTIN | 1 | Unknown | 100 MG DAILY | U | 0 | 100 | MG | |||||||
| 125643601 | 12564360 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125643601 | 12564360 | 4 | SS | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125643601 | 12564360 | 5 | SS | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125643601 | 12564360 | 6 | SS | GINGKO BILIOBA | GINKGO | 1 | Unknown | UNK | U | 0 | |||||||||
| 125643601 | 12564360 | 7 | SS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
| 125643601 | 12564360 | 8 | SS | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125643601 | 12564360 | 9 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125643601 | 12564360 | 1 | Product used for unknown indication |
| 125643601 | 12564360 | 2 | Product used for unknown indication |
| 125643601 | 12564360 | 3 | Product used for unknown indication |
| 125643601 | 12564360 | 4 | Product used for unknown indication |
| 125643601 | 12564360 | 5 | Product used for unknown indication |
| 125643601 | 12564360 | 6 | Product used for unknown indication |
| 125643601 | 12564360 | 7 | Product used for unknown indication |
| 125643601 | 12564360 | 8 | Product used for unknown indication |
| 125643601 | 12564360 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125643601 | 12564360 | OT |
| 125643601 | 12564360 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125643601 | 12564360 | Acute kidney injury | |
| 125643601 | 12564360 | Asthenia | |
| 125643601 | 12564360 | Drug interaction | |
| 125643601 | 12564360 | Muscle atrophy | |
| 125643601 | 12564360 | Myalgia | |
| 125643601 | 12564360 | Rhabdomyolysis | |
| 125643601 | 12564360 | Tenderness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |